Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040970

Options or other derivatives

  • Director acquired 5,714 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ezekowitz Alan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-07-18 Grant or award : show line 1 in the form Stock Option (right to buy) +5,714 5,714 D
Loading xslF345X03/a4.xml…